How can a startup provide a return on investment from bringing the woolly mammoth back from the dead? Ben Lamm, the CEO and cofounder of Colossal Biosciences, the startup developing "de-extinction ...

Colossal Biosciences, a Texas-based company, genetically engineered a woolly mouse, marking an achievement toward its goal of resurrecting extinct species like the woolly mammoth. The woolly mouse ...

Feb. 18, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced ...

Feb 18 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is seeking up to $830 million in damages from KBP Biosciences, according to a ruling by a Singapore court, as the Danish drugmaker says it ...

according to Colossal Biosciences. The private Dallas company is behind efforts to resurrect the mammoth and other extinct animals. Colossal said its woolly mouse would enable its scientists to ...

The Danish pharma giant plans to seek $830 million in damages from Singapore-based KBP Biosciences and KBP’s founder and executive chairman, Zhenhua Huang, Ph.D., according to a Feb. 14 ruling ...

Story Jan. 10 - Shoreline Biosciences: The cell therapy biotech plans to let go of an undisclosed number of employees tied to a project with Gilead Sciences’ Kite Pharma. Story Jan. 9 - IGM ...

We're fourth in the UK in terms of the quality of our research (REF 2021). In the REF 2021, 98 per cent of research and impact from the School of Biosciences has been classed as world-leading or ...

Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial ...

After hours: March 11 at 5:39:39 PM EDT Loading Chart for DTIL ...